Floatz logo

Aspirin

Coronary Atherosclerosis

Ukrainian Medical Stomatological AcademySmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Coronary Atherosclerosis cohort.

Asset / SponsorPhaseRating
Bisoprolol Fumarate
Ukrainian Medical Stomatological Academy
Phase 4BB
Isosorbide Dinitrate
Ukrainian Medical Stomatological Academy
Phase 4BB
Rosuvastatin
Ukrainian Medical Stomatological Academy
Phase 4BB
Pioglitazone
Ukrainian Medical Stomatological Academy
Phase 4BB
Ezetimibe
Samsung Medical Center
Phase 4BB
Corpril
Ukrainian Medical Stomatological Academy
Phase 4BB
Rimonabant
Sanofi
Phase 3CC
Edoxaban
Asan Medical Center
UnknownD

Same molecule, other indications

Aspirin is also rated in:

myocardial infarctionActive
A
Indicative · Phase 4
83 / 100
View asset →
coronary artery disorderActive
BBB
Indicative · Phase 4
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative · Phase 4
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →